Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Kronik

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Mathematical Medicine and Biology : a Journal of the IMA|April 19, 2015
Improving Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer by adding interleukin 2 (IL-2): a mathematical modelSvetlana Bunimovich-Mendrazitsky, Sarel Halachmi, Natalie Kronik
Cancer Immunology, Immunotherapy : CII|September 8, 2007
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamicsNatalie Kronik, Yuri Kogan, Vladimir Vainstein, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Improving T-cell immunotherapy for melanoma through a mathematically motivated strategy: efficacy in numbers?Natalie Kronik, Yuri Kogan, Paul G Schlegel, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2020
Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approachAnat Globerson Levin, Natalie Kronik, Tamar Shiloach, et al.
Plos One|December 15, 2010
Predicting outcomes of prostate cancer immunotherapy by personalized mathematical modelsNatalie Kronik, Yuri Kogan, Moran Elishmereni, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Mathematical Medicine and Biology : a Journal of the IMA|April 19, 2015
Improving Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer by adding interleukin 2 (IL-2): a mathematical modelSvetlana Bunimovich-Mendrazitsky, Sarel Halachmi, Natalie Kronik
Cancer Immunology, Immunotherapy : CII|September 8, 2007
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamicsNatalie Kronik, Yuri Kogan, Vladimir Vainstein, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Improving T-cell immunotherapy for melanoma through a mathematically motivated strategy: efficacy in numbers?Natalie Kronik, Yuri Kogan, Paul G Schlegel, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2020
Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approachAnat Globerson Levin, Natalie Kronik, Tamar Shiloach, et al.
Plos One|December 15, 2010
Predicting outcomes of prostate cancer immunotherapy by personalized mathematical modelsNatalie Kronik, Yuri Kogan, Moran Elishmereni, et al.
Pageof 1